A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Wanda Health Announces a New Partnership with Florida-based Smart Meter Corp

Wanda Health Inc, a leading telehealth company that provides a virtual care platform for patients with heart failure and other chronic diseases, today announced a partnership with Florida-based Smart Meter Corporation, a cellular-enabled remote monitoring devices provider, to ensure reliable, high quality data capture from patients, regardless of access to smart devices and internet connectivity.

The partnership will provide intelligent virtual care, device logistics, timely alert management and patient engagement services to complement the extensive collection of care management capabilities that comprise the Wanda Health intelligent virtual care platform.  Designed specifically for healthcare providers in North America and Europe, the partnership will give optimal data from cellular-connected devices no matter where they are located.

The growth in the digitally-connected healthcare market has exploded since the beginning of the Covid-19 pandemic, and the type of solutions and services offered by Wanda Health are seeing increased demand on all fronts. Indeed, the global connected healthcare market size is projected to grow from approximately US$51.59 billion in 2021 to approximately US$297.95 billion in 2028*, with market demand exploding across all regions, particularly in North America, Europe, Asia Pacific and elsewhere.

Wanda Health Inc is a portfolio company of EMV Capital, a wholly owned subsidiary of NetScientific PLC. Starting as a UCLA spin-out, Wanda Health’s platform warns healthcare practitioners and patients of potential adverse medical incidents, thus helping identify urgent medical care and treatment needs, and contributing to reduced re-admissions and emergency department visits. This new partnership will boost the company’s offering and provide increased service to those located in remote areas where connectivity can falter.

“Customers demand accuracy and precision in both the quality of the readings and the transmission of that data,” said Casey Pittock, Smart Meter CEO. “The combination of Smart Meter devices and the Wanda Health RPM solution will result in delivering the timely information that will improve care and facilitate billing for remote patient monitoring services.”

“Our partnership with Smart Meter will continue to enhance our intelligent virtual care platform, by increasing access to not only quality but quantity of ingested patient data,” Tom Smith, CEO of Wanda Health said. “This will help us to reach new patient populations and enhance our program offerings to healthcare providers.”

“As part of our trans-Atlantic thesis, our investment in Wanda has helped the company to focus on scaling its connected health offering in the US healthcare market, Dr Ilian Iliev, Managing Director for EMV Capital and CEO for NetScientific PLC noted.  “During COVID this market saw an explosion of demand as digitisation of healthcare services took off. We are pleased to see the results of the team’s work over the last few years, as Wanda moves towards accelerated commercialisation in the US, while exploring growth opportunities in the UK and Europe.”

*Ref: Fortune Business Insights

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy